Adjuvant therapy in head and neck cancer

Ca-A Cancer Journal for Clinicians

Volumn 48, Issue 4, 1998, Pages 199-209

  Vikram, Bhadrasain ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ISOTRETINOIN; KI 67 ANTIGEN; PROTEIN P53;

ADJUVANT CHEMOTHERAPY; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL TRIAL; HEAD AND NECK CANCER; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; META ANALYSIS; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; REVIEW; SMOKING;

EID: 0031830474     PISSN: 00079235     EISSN: None     Source Type: Journal    
DOI: 10.3322/canjclin.48.4.199     Document Type: Review

References (91)

1. Landis SH, Murray T, Bolden S, et al: Cancer statistics, 1998. CA Cancer J Clin 1998;48:6-29.
2. Looser KG, Shah JP, Strong EW: The significance of "positive" margins in surgically resected epidermoid carcinoma. Head Neck Surg 1978;1:107-111.
3. Strong EW: Preoperative radiation and radical neck dissection. Surg Clin North Am 1969;49:271-276.
4. Kramer S, Gelber RD, Snow JB, et al: Combined radiation therapy and surgery in the management of advanced head and neck cancer: Final report of study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg 1987;10:49-55.
5. Head and Neck Contracts Program: Adjuvant chemotherapy treatment for advanced head and neck squamous carcinomas: Final report of the Head and Neck Contracts Program. Cancer 1987;60:301-311.
6. Laramore GE, Scott CB, Al-Sarraf M, et al: Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report on Intergroup study 0034. Int J Radiat Oncol Biol Phys 1992;23:705-713.
7. Guillamondegui OM, Byers RM, Luna MA, et al: Aggressive surgery in treatment for parotid cancer: The role of adjunctive postoperative radiotherapy. AJR Am J Roentgenol Radium Ther Nucl Med 1975;123:49-54.
8. Armstrong JG, Harrison LB, Spiro RH, et al: Malignant tumors of major salivary gland origin: A matched-pair analysis of the role of combined surgery and postoperative radiotherapy. Arch Otolaryngol Head Neck Surg 1990;116:290-293.
9. McKenna WG, Barnes MM, Kinsella TJ, et al: Combined modality treatment of adult soft tissue sarcomas of the head and neck. Int J Radiat Oncol Biol Phys 1987;13:1127-1133.
10. Ang KK, Peters LJ, Weber RS, et al: Postoperative radiotherapy for cutaneous melanoma of the head and neck region. Int J Radiat Oncol Biol Phys 1994;30:795-798.
11. Schlumberger MJ: Papillary and follicular thyroid carcinoma. N Engl J Med 1998;338:297-306.
12. Lee JG: Detection of residual carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: A study of surgical margins. Trans Am Acad Ophthalmol Otolaryngol 1974;78:49-53.
13. Scholl P, Byers RM, Batsakis JG, et al: Microscopic cut-through of cancer in the surgical treatment of squamous carcinoma of the tongue: Prognostic and therapeutic implications. Am J Surg 1986;152:354-360.
14. Byers RM, Bland KI, Borlase B, et al: The prognostic and therapeutic value of frozen section determinations in the surgical treatment of squamous carcinoma of the head and neck. Am J Surg 1978;136:525-528.
15. Jacobs JR, Ahmad K, Casiano R, et al: Implications of positive surgical margins. Laryngoscope 1993;103:64-68.
16. Vikram B, Strong EW, Shah JP, et al: Failure at the primary site following multimodality treatment in advanced head and neck cancer. Head Neck Surg 1984;6:720-723.
17. Parsons JT, Mendenhall WM, Stringer SP, et al: An analysis of factors influencing the outcome of postoperative irradiation for squamous cell carcinoma of the oral cavity. Int J Radiat Oncol Biol Phys 1997;39:137-148.
18. Huang D, Johnson CR, Schmidt-Ullrich RK, et al: Incompletely resected advanced squamous cell carcinoma of the head and neck: The effectiveness of adjuvant vs. salvage radiotherapy. Radiother Oncol 1992;24:87-93.
19. Vikram B, Mishra S: Permanent iodine-125 implants in postoperative radiotherapy for head and neck cancer with positive surgical margins. Head Neck 1994;16:155-157.
20. Beitler JJ, Smith RV, Silver CE, et al: Close or positive margins after surgical resection for the head and neck cancer patient: The addition of brachytherapy improves local control. Int J Radiat Oncol Biol Phys 1998;40:313-317.
21. Marks JE, Freeman RB, Ogura JH: Carcinoma of the supraglottic larynx. AJR Am J Roentgenol 1979;132:255-260.
22. Levendag P, Sessions R, Vikram B, et al: The problem of neck relapse in early stage supraglottic larynx cancer. Cancer 1989;63:345-348.
23. Spiro RH, Strong EW: Surgical treatment of cancer of the tongue. Surg Clin North Am 1974;54:759-765.
24. Marchetta FC, Sako K, Razack MS: Management of "localized" oral cancer. Am J Surg 1977;134:448-449.
25. Clayman GL, Frank DK: Selective neck dissection of anatomically appropriate levels is as efficacious as modified radical neck dissection for eleclive treatment of the clinically negative neck in patients with squamous cell carcinoma of the upper respiratory and digestive tracts. Arch Otolaryngol Head Neck Surg 1998;124:348-352.
26. Feinmesser R, Freeman JL, Noyek AM, et al: Metastatic neck disease: A clinical radiologic, pathologic correlative study. Arch Otolaryngol Head Neck Surg 1987;113:1307-1311.
27. Som PM: Lymph nodes of the neck. Radiology 1987;165:593-600.
28. Takes RP, Righi P, Meeuwis CA, et al: The value of ultrasound with ultrasound-guided fine-needle aspiration biopsy compared to computed tomography in the detection of regional metastases in the clinically negative neck. Int J Radiat Oncology Biol Phys 1998;40:1027-1032.
29. Bagshaw MA, Thompson RW: Elective irradiation of the neck in patients with primary carcinoma of the head and neck. JAMA 1971;217:456-458.
30. Rabuzzi DD, Chung CT, Sagerman RH: Prophylactic neck irradiation. Archives of Otolaryngology 1980;106:454-455.
31. Harwood AR, Beale FA, Cummings BJ, et al: Management of early supraglottic laryngeal carcinoma by irradiation with surgery in reserve. Archives of Otolaryngology 1983;109:583-585.
32. Ghossein NA, Bataini P: The role of radiotherapy in the treatment of neck metastases from head and neck cancer, in Wolf GT (ed): Head and Neck Oncology. Boston, Martinus Ninjhoff, 1984, pp 169-197.
33. Fletcher GH: Place of irradiation in the management of head and neck cancers. Semin Oncol 1977;4:375-385.
34. Vikram B, Berson AM, Ng JPT, et al: Elective postoperative radiation therapy following supraglottic laryngectomy: A simple new technique. Radiat Oncol Investig 1996;4:239-242.
35. Cachin Y, Eschwege F: Combination of radiotherapy and surgery in the treatment of head and neck cancers. Cancer Treat Rev 1975;2:177-191.
36. Vikram B, Strong EW, Shah JP, et al: Failure in the neck following multimodality treatment for advanced head and neck cancer. Head and Neck Surgery 1984;6:724-729.
37. Huang DT, Johnson CR, Schmidt-Ullrich R, et al: Postoperative radiotherapy in head and neck carcinoma with extracapsular lymph node extension and/or positive resection margins: A comparative study. Int J Radiat Oncol Biol Phys 1992;23:737-742.
38. Lundahl EL, Foote RL, Bonner JA, et al: Combined neck dissection and postoperative radiation therapy in the management of the high-risk neck: A matched-pair analysis. Int J Radiat Oncol Biol Phys 1998;40:529-534.
39. Peters LJ, Goepfert H, Ang KK, et al: Evaluation of the dose for postoperative radiation therapy of head and neck cancer: First report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 1993;26:3-11.
40. Graeber TG, Osmanian C, Jacks T, et al: Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature 1996;379:88-91.
41. Ang KK, Trotti A, Garden A, et al: Importance of overall time factor in postoperative radiotherapy. Proceedings of the Fourth International Conference on Head and Neck Cancer, July 28-August 1, 1996. Toronto. Arlington, VA, The Society of Head and Neck Surgeons, 1996, pp 231-235.
42. Fowler JF, Lindstrom MJ: Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 1992;23:457-467.
43. Vikram B, Strong, EW, Shah JP, et al: Failure at distant sites following multimodality treatment for advanced head and neck cancer. Head and Neck Surgery 1984;6:730-733.
44. Rentschler RE, Wilbur DW, Petti GH, et al: Adjuvant methotrexate escalated to toxicity for resectable stage III and IV squamous head and neck carcinomas: A prospective, randomized study. J Clin Oncol 1987;5:278-285.
45. Schuller DE, Metch B, Stein DW, et al: Preoperative chemotherapy in advanced resectable head and neck cancer: Final report of the Southwest Oncology Group. Laryngoscope 1988;98:1205-1211.
46. Jortay A, Demard F, Dalesio O, et al: A randomized EORTC study on the effect of preoperative polychemotherapy in pyriform sinus carcinoma treated by pharyngolaryngectomy and irradiation: Results from 5 to 10 years. Acta Chir Belg 1990;90:115-122.
47. Richard JM, Kramar A, Molinari R, et al: Randomised EORTC head and neck cooperative group trial of preoperative intra-arterial chemotherapy in oral cavity and oropharynx carcinoma. Eur J Cancer 1991;27:821-827.
48. Szpirglas H, Chastang C, Bertrand JC: Adjuvant treatment of tongue and floor of the mouth cancers. Recent Results Cancer Res 1978;68:309-317.
49. Taylor SG 4th, Applebaum E, Showel JL, et al: A randomized trial of adjuvant chemotherapy in head and neck cancer. J Clin Oncol 1985;3:672-679.
50. Kun LE, Toohil RJ, Holoye PY, et al: A randomized study of adjuvant chemotherapy for cancer of the upper aerodigestive tract. Int J Radiat Oncol Biol Phys 1986;12:173-178.
51. Ervin TJ, Clark JR, Weichselbaum RR, et al: An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck. J Clin Oncol 1987;5:10-20.
52. Fu KK, Phillips TL, Silverberg IJ, et al: Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: Update of a Northern California Oncology Group randomized trial. J Clin Oncol 1987;5:1410-1418.
53. Rossi A, Molinari R, Boracchi P, et al: Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: Results of a 4-year multicenter randomized study. J Clin Oncol 1988;6:1401-1410.
54. Jacobs C, Makuch R: Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: A subset analysis of the Head and Neck Contracts Program. J Clin Oncol 1990;8:838-847.
55. Paccagnella A, Orlando A, Marchiori C, et al: Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: A study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst 1994;86:265-272.
56. Haffty BG, Son YH, Sasaki CT, et al: Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: Results from two randomized clinical trials. Int J Radiat Oncol Biol Phys 1993;27:241-250.
57. Bachaud JM, Cohen-Jonathan E, Alzieu C, et al: Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: Final report of a randomized trial. Int J Radiat Oncol Biol Phys 1996;36:999-1004.
58. Cooper JS, Farnan NC, Asbell SO, et al: Recursive partitioning analysis of 2105 patients treated in Radiation Therapy Oncology Group studies of head and neck cancer. Cancer 1996;77:1905-1911.
59. Wang CC: Improved local control of nasopharyngeal carcinoma after intracavitary brachytherapy boost. Am J Clin Oncol 1991;14:5-8.
60. Vikram B: Permanent iodine-125 (I-125) boost after teletherapy in primary cancers of the nasopharynx is safe and highly effective: Long-term results. Int J Radiat Oncol Biol Phys 1997;38:1140-1141. Letter.
61. Al-Sarraf M, Le Blanc M, Giri PGS, et al: Chemoradiotherapy vs radiotherapy in patients with locally advanced nasopharyngeal cancer: Phase III randomized Intergroup study (0099). J Clin Oncol 1998;16:1310-1317.
62. Arcangeli G, Nervi C, Righini R, et al: Combined radiation and drugs: The effect of intra-arterial chemotherapy followed by radiotherapy in head and neck cancer. Radiother Oncol 1983;1:101-107.
63. Stell PM, Dalby JE, Strickland P, et al: Sequential chemotherapy and radiotherapy in advanced head and neck cancer. Clin Radiol 1983;34:463-467.
64. Stolwijk C, Wagener DJ, Van den Broek P, et al: Randomized neo-adjuvant chemotherapy trial for advanced head and neck cancer. Neth J Med 1985;28:347-351.
65. Toohill RJ, Anderson T, Byhardt RW, et al: Cisplatin and fluorouracil as neoadjuvant therapy in head and neck cancer: A preliminary report. Arch Otolaryngol Head Neck Surg 1987;113:758-761.
66. Martin M, Hazan A, Vergnes L, et al: Randomized study of 5 fluorouracil and cis platin as neoadjuvant therapy in head and neck cancer: A preliminary report. Int J Radiat Oncol Biol Phys 1990;19:973-975.
67. Mazeron JJ, Martin M, Brun B, et al: Induction chemotherapy in head and neck cancer: Results of a phase III trial. Head Neck 1992;14:85-91.
68. Jaulerry C, Rodriguez J, Brunin F, et al: Induction chemotherapy in advanced head and neck tumors: Results of two randomized trials. Int J Radiat Oncol Biol Phys 1992;23:483-489.
69. Chan AT, Teo PM, Leung TW, et al: A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1995;33:569-577.
70. Anonymous: Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (> or = N2, M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival: International Nasopharynx Cancer Study Group: VUMCA I trial. Int J Radiat Oncol Biol Phys 1996;35:463-469.
71. Lo TC, Wiley AL Jr, Ansfield FJ, et al: Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: A randomized study. Am J Roentgenol 1976;126:229-235.
72. Ansfield FJ, Ramirez G, Davis HL Jr, et al: Treatment of advanced cancer of the head and neck. Cancer 1970;25:78-82.
73. Shanta V, Krishnamurthi S: Combined bleomycin and radiotherapy in oral cancer. Clin Radiol 1980;31:617-620.
74. Gupta NK, Pointon RC, Wilkinson PM: A randomised clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer. Clin Radiol 1987;38:575-581.
75. Sanchiz F, Milla A, Torner J, et al: Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer. Int J Radiat Oncol Biol Phys 1990;19:1347-1350.
76. Smid L, Lesnicar H, Zakotnik B, et al: Radiotherapy, combined with simultaneous chemotherapy with mitomycin C and bleomycin for inoperable head and neck cancer: Preliminary report. Int J Radiat Oncol Biol Phys 1995;32:769-775.
77. Adelstein DJ, Saxton JP, Lavertu P, et al: A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results. Head Neck 1997;19:567-575.
78. Southeast Cooperative Oncology Group: A randomized trial of combined multidrug chemotherapy and radiotherapy in advanced squamous cell carcinoma of the head and neck: An interim report from the SECOG participants. Eur J Surg Oncol 1986;12:289-295.
79. Merlano M, Benasso M, Corvo R, et al: Five- year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 1996;88:583-589.
80. Vikram B: Prognostic value of tumor regression during radiotherapy or chemoradiotherapy of advanced head and neck cancers: Regarding Jaulerry et al. Int J Radiat Oncol Biol Phys 1996;34:971. Letter.
81. Raybaud-Diogene H, Fortin A, Morency R, et al: Markers of radioresistance in squamous cell carcinomas of the head and neck: A clinicopathologic and immunohistochemical study. J Clin Oncol 1997;15:1030-1038.
82. Bradford CR, Zhu S, Wolf GT, et al: Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer: Department of Veterans Affairs Laryngeal Cancer Study Group. Otolaryngol Head Neck Surg 1995;113:408-412.
83. Browman GP, Wong G, Hudson I, et al: Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 1993;328:159-163.
84. Vikram B: Changing patterns of failure in advanced head and neck cancer. Arch Otolaryngol 1984;110:564-565.
85. Hong WK, Lippman SM, Itri LM, et al: Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N Engl J Med 1990;323:795-801.
86. Bartecchi CE, MacKenzie TD, Schrier RW: The human costs of tobacco use (part I). N Engl J Med 1994;330:907-912.
87. Cummings SR, Rubin SM, Oster G: The cost-effectiveness of counseling smokers to quit. JAMA 1989;261:75-79.
88. Gilpin EA, Pierce JP, Johnson M, et al: Physician advice to quit smoking: Results from the 1990 California Tobacco Survey. J Gen Intern Med 1993;8:549-553.
89. Prochaska JO, DiClemente CC, Velicer WF, et al: Standardized, individualized, interactive, and personalized self-help programs for smoking cessation. Health Psychol 1993;12:399-405.
90. Cloos J, Spitz MR, Schantz SP, et al: Genetic susceptibility to head and neck squamous cell carcinoma. J Natl Cancer Inst 1996;88:530-535.
91. Vikram B, Farr HW: Adjuvant radiation therapy in locally advanced head and neck cancer. CA Cancer J Clin 1983;33:134-138.